Us Anti-inflammatory Therapeutics Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Anti-inflammatory Therapeutics Market was valued at USD 82 Billion in 2022 and is projected to reach USD 120 Billion by 2030, growing at a CAGR of 5.1% from 2024 to 2030.
The U.S. anti-inflammatory therapeutics market is experiencing significant growth, driven by the increasing prevalence of chronic inflammatory diseases and advancements in medical research. In 2024, the market was valued at approximately USD 105.56 billion and is projected to reach USD 158.36 billion by 2034, reflecting a compound annual growth rate (CAGR) of 4.14%. This upward trend underscores the escalating demand for effective anti-inflammatory treatments across various medical conditions.
Several factors contribute to this market expansion. The aging population in the United States is more susceptible to inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel diseases. Additionally, heightened awareness and improved diagnostic capabilities have led to earlier detection and treatment, further propelling market growth.
In terms of therapeutic options, the market is diverse, encompassing non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologics. NSAIDs remain widely used due to their efficacy and cost-effectiveness. However, biologics, particularly monoclonal antibodies targeting specific inflammatory pathways, are gaining prominence. These biologics offer targeted treatment with potentially fewer side effects, appealing to both healthcare providers and patients.
Notably, the U.S. Food and Drug Administration (FDA) has recently approved several innovative treatments. For instance, Johnson & Johnson's Tremfya, initially approved for psoriasis, has received expanded approval for the treatment of ulcerative colitis, a chronic inflammatory bowel disease. This development provides patients with additional therapeutic options and highlights the dynamic nature of the anti-inflammatory therapeutics market.
Looking ahead, the market is expected to continue its growth trajectory, driven by ongoing research and development efforts, the introduction of novel therapies, and an increasing patient population. The integration of advanced technologies and personalized medicine approaches is anticipated to further enhance treatment outcomes, solidifying the U.S. as a leader in the global anti-inflammatory therapeutics market.
Get an In-Depth Research Analysis of the Global Anti-inflammatory Therapeutics Market Size And Forecast [2025-2032]
Â
AbbVie
Amgen
Johnson & Johnson
Pfizer
Boehringer Ingelheim
Eli Lilly
Novartis
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Anti-inflammatory Therapeutics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Anti-inflammatory Therapeutics Market
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroids
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Biologics
Targeted Synthetic DMARDs
Oral
Intravenous
Topical
Injectable
Inhaled
Arthritis
Autoimmune Diseases
Respiratory Disorders
Cardiovascular Diseases
Skin Disorders
COX Inhibitors
IL Inhibitors
TNF-Alpha Inhibitors
JAK Inhibitors
Arachidonic Acid Pathway Modulators
Hospitals
Outpatient Clinics
Home Healthcare Settings
Pharmacies
Long-term Care Facilities
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Anti-inflammatory Therapeutics Market Research Analysis
1. Introduction of the Global Anti-inflammatory Therapeutics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Anti-inflammatory Therapeutics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Anti-inflammatory Therapeutics Market, By Type
6. Global Anti-inflammatory Therapeutics Market, By Application
7. Global Anti-inflammatory Therapeutics Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Anti-inflammatory Therapeutics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/